指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

世卫组织结核综合指南，模块4：治疗-耐药结核治疗

WHO

具有耐药性的结核病菌株比具有药物敏感性的菌株更难治疗，并且威胁着世界在实现世界卫生组织《终结结核病战略》设定的目标方面取得进展。世卫组织估计，估计每年约有五十万例多药耐药或利福平耐药（MDR / RR

中文标题：

世卫组织结核综合指南，模块4：治疗-耐药结核治疗

发布机构：

发布日期：

简要介绍：

具有耐药性的结核病菌株比具有药物敏感性的菌株更难治疗，并且威胁着世界在实现世界卫生组织《终结结核病战略》设定的目标方面取得进展。世卫组织估计，估计每年约有五十万例多药耐药或利福平耐药（MDR / RR-TB）病例。但是，据估计只有三分之一获得了有效的治疗，其中只有一半以上获得了成功的治疗结果。因此，迫切需要基于可得的最新和最全面的证据，对DR-TB的患者进行治疗和护理的循证政策建议。在这方面，世界卫生组织《结核病综合指南》模块4：治疗-耐药结核病治疗 履行世界卫生组织的任务，向会员国的卫生保健专业人员介绍如何改善对DR-TB患者的治疗和护理。

相关资料下载：
[AttachmentFileName(sort=1, fileName=世卫组织结核综合指南，模块4：治疗-耐药结核治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=43b531c00209e39a, title=世卫组织结核综合指南，模块4：治疗-耐药结核治疗, enTitle=, guiderFrom=WHO, authorId=0, author=, summary=具有耐药性的结核病菌株比具有药物敏感性的菌株更难治疗，并且威胁着世界在实现世界卫生组织《终结结核病战略》设定的目标方面取得进展。世卫组织估计，估计每年约有五十万例多药耐药或利福平耐药（MDR / RR, cover=https://img.medsci.cn/2021514/1620963485044_5433779.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=null, originalUrl=, linkOutUrl=, content=<p><span style="color: #1a1a1a;">具有耐药性的结核病菌株比具有药物敏感性的菌株更难治疗，并且威胁着世界在实现世界卫生组织《终结结核病战略》设定的目标方面取得进展。世卫组织估计，估计每年约有五十万例多药耐药或利福平耐药（MDR / RR-TB）病例。但是，据估计只有三分之一获得了有效的治疗，其中只有一半以上获得了成功的治疗结果。因此，迫切需要基于可得的最新和最全面的证据，对DR-TB的患者进行治疗和护理的循证政策建议。在这方面，</span><em style="color: #1a1a1a;">世界卫生组织《结核病综合指南》模块4：治疗-耐药结核病治疗</em><span style="color: #1a1a1a;">&nbsp;履行世界卫生组织的任务，向会员国的卫生保健专业人员介绍如何改善对DR-TB患者的治疗和护理。</span></p> <p><span style="color: #1a1a1a;"><img class="wscnph" src="https://img.medsci.cn/2021514/1620963485044_5433779.png" /></span></p>, tagList=[], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1678, appHits=177, showAppHits=0, pcHits=483, showPcHits=1498, likes=0, shares=11, comments=9, approvalStatus=1, publishedTime=Fri May 14 11:38:41 CST 2021, publishedTimeString=null, pcVisible=1, appVisible=1, editorId=5433779, editor=Oranhyg是正经人, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=Oranhyg是正经人, createdTime=Fri May 14 11:38:33 CST 2021, updatedBy=5433779, updatedName=Oranhyg是正经人, updatedTime=Sun Dec 31 17:05:33 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=世卫组织结核综合指南，模块4：治疗-耐药结核治疗.pdf)])
世卫组织结核综合指南，模块4：治疗-耐药结核治疗.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194731, encodeId=1d931194e31dd, content=耐单药利福平的治疗周期是多久, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f226509413, createdName=ms4000000833037546, createdTime=Fri Feb 18 09:58:48 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070267, encodeId=1f4210e0267a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:48 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015676, encodeId=89c910156e6eb, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b2f5598866, createdName=ms3000001972853274, createdTime=Wed Sep 08 13:32:07 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002490, encodeId=42881002490c3, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:07:42 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970018, encodeId=85e09e00185d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/01c0bf9a79a7413bb8f3d743efa09258/0d6eeea2308148bf92bcad385ed13379.jpg, createdBy=a1545490722, createdName=罗琴, createdTime=Tue Jun 01 09:23:01 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2022-02-18 ms4000000833037546

    耐单药利福平的治疗周期是多久

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1194731, encodeId=1d931194e31dd, content=耐单药利福平的治疗周期是多久, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f226509413, createdName=ms4000000833037546, createdTime=Fri Feb 18 09:58:48 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070267, encodeId=1f4210e0267a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:48 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015676, encodeId=89c910156e6eb, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b2f5598866, createdName=ms3000001972853274, createdTime=Wed Sep 08 13:32:07 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002490, encodeId=42881002490c3, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:07:42 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970018, encodeId=85e09e00185d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/01c0bf9a79a7413bb8f3d743efa09258/0d6eeea2308148bf92bcad385ed13379.jpg, createdBy=a1545490722, createdName=罗琴, createdTime=Tue Jun 01 09:23:01 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2021-11-14 脊柱 doctor

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194731, encodeId=1d931194e31dd, content=耐单药利福平的治疗周期是多久, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f226509413, createdName=ms4000000833037546, createdTime=Fri Feb 18 09:58:48 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070267, encodeId=1f4210e0267a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:48 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015676, encodeId=89c910156e6eb, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b2f5598866, createdName=ms3000001972853274, createdTime=Wed Sep 08 13:32:07 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002490, encodeId=42881002490c3, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:07:42 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970018, encodeId=85e09e00185d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/01c0bf9a79a7413bb8f3d743efa09258/0d6eeea2308148bf92bcad385ed13379.jpg, createdBy=a1545490722, createdName=罗琴, createdTime=Tue Jun 01 09:23:01 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2021-09-08 ms3000001972853274

    ！

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1194731, encodeId=1d931194e31dd, content=耐单药利福平的治疗周期是多久, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f226509413, createdName=ms4000000833037546, createdTime=Fri Feb 18 09:58:48 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070267, encodeId=1f4210e0267a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:48 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015676, encodeId=89c910156e6eb, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b2f5598866, createdName=ms3000001972853274, createdTime=Wed Sep 08 13:32:07 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002490, encodeId=42881002490c3, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:07:42 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970018, encodeId=85e09e00185d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/01c0bf9a79a7413bb8f3d743efa09258/0d6eeea2308148bf92bcad385ed13379.jpg, createdBy=a1545490722, createdName=罗琴, createdTime=Tue Jun 01 09:23:01 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2021-07-25 ms8000001011137665

    好的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1194731, encodeId=1d931194e31dd, content=耐单药利福平的治疗周期是多久, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f226509413, createdName=ms4000000833037546, createdTime=Fri Feb 18 09:58:48 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070267, encodeId=1f4210e0267a1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:48 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015676, encodeId=89c910156e6eb, content=！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b2f5598866, createdName=ms3000001972853274, createdTime=Wed Sep 08 13:32:07 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002490, encodeId=42881002490c3, content=好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=ms8000001011137665, createdTime=Sun Jul 25 13:07:42 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970018, encodeId=85e09e00185d, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/01c0bf9a79a7413bb8f3d743efa09258/0d6eeea2308148bf92bcad385ed13379.jpg, createdBy=a1545490722, createdName=罗琴, createdTime=Tue Jun 01 09:23:01 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2021-06-01 罗琴

    棒

    0